Codexis (CDXS) Cash from Operations Growth (1y) (2011 - 2026)
Codexis (CDXS) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Codexis | 135.70 Mn | 70.56 Mn | 13.18 Mn | 4.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.70% |
| Dec 31, 2025 | 222.01% |
| Sep 30, 2025 | 40.68% |
| Jun 30, 2025 | -47.66% |
| Mar 31, 2025 | -77.15% |
| Dec 31, 2024 | -49.21% |
| Sep 30, 2024 | 20.35% |
| Jun 30, 2024 | 24.36% |
| Mar 31, 2024 | 15.45% |
| Dec 31, 2023 | -324.47% |
| Sep 30, 2023 | -182.61% |
| Jun 30, 2023 | -637.60% |
| Mar 31, 2023 | 17.65% |
| Dec 31, 2022 | 645.00% |
| Sep 30, 2022 | 10,378.13% |
| Jun 30, 2022 | 73.71% |
| Mar 31, 2022 | -73.70% |
| Dec 31, 2021 | 144.24% |
| Sep 30, 2021 | 94.47% |
| Jun 30, 2021 | 17.65% |